Treatment of experimental sepsis-induced immunoparalysis with TNF
- 1 January 2003
- journal article
- Published by Elsevier in Immunobiology
- Vol. 208 (4) , 381-389
- https://doi.org/10.1078/0171-2985-00282
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (EC142/3-2, Ma760/10, SPP 1110/FR 448/4, UR41/1-1)
This publication has 22 references indexed in Scilit:
- Tumor Necrosis Factor-Dependent Adhesions as a Major Protective Mechanism Early in Septic Peritonitis in MiceInfection and Immunity, 2001
- Endotoxin, Endotoxin‐Neutralizing‐Capacity, sCD14, sICAM‐1, and Cytokines in Patients With Various Degrees of Alcoholic Liver DiseaseAlcohol, Clinical and Experimental Research, 2001
- What is the role of interleukin 10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant?Surgery, 1999
- Clinical Aspects: From Systemic Inflammation to 'ImmunoparalysisPublished by S. Karger AG ,1999
- Interferon Gamma-1b in the Treatment of Compensatory Anti-inflammatory Response SyndromeArchives of internal medicine (1960), 1997
- Monocyte deactivation-rationale for a new therapeutic strategy in sepsisIntensive Care Medicine, 1996
- Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.The Journal of Experimental Medicine, 1996
- Critical protective role of mast cells in a model of acute septic peritonitisNature, 1996
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Sepsis and septic shock—A review of laboratory models and a proposalJournal of Surgical Research, 1980